retatrutide phase 2 trial results obesity ๐จ Today, retatrutide, the GIP/GLP-1/glucagon triple agonist, just delivered TRIUMPH-2 top-line results. A study in those with concurrent and type diabetes. ๐ Mean body weight change at 80 weeks: โฌ๏ธ This is exciting. ๐ The
Pay in 4 interest-free payments of $7.28 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Aug 21 - Aug 26


























